Mark S. MD Gelder

Insider Reports History

Entity
Individual
Location
C/O A.P. Pharma, Inc., 123 Saginaw Drive, Redwood City, CA
Signature
/s/ Mark Guerin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark S. MD Gelder:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Onconova Therapeutics, Inc. CHIEF MEDICAL OFFICER Restricted Stock Units 20.7K $13.8K $0.67 Mar 13, 2023 Direct
Onconova Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (right to purchase) 62K Mar 13, 2023 Direct

Insider Reports Filed by Mark S. MD Gelder

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONTX Onconova Therapeutics, Inc. Mar 13, 2023 2 $0 4 Mar 14, 2023 CHIEF MEDICAL OFFICER
ONTX Onconova Therapeutics, Inc. Feb 7, 2023 3 -$1.69K 4 Feb 8, 2023 CHIEF MEDICAL OFFICER
ONTX Onconova Therapeutics, Inc. Aug 2, 2022 3 -$1.5K 4 Aug 4, 2022 CHIEF MEDICAL OFFICER
ONTX Onconova Therapeutics, Inc. Feb 7, 2022 2 $0 4 Feb 9, 2022 Chief Medical Officer
ONTX Onconova Therapeutics, Inc. Sep 28, 2021 1 $10K 4 Sep 29, 2021 Chief Medical Officer
ONTX Onconova Therapeutics, Inc. Aug 2, 2021 2 $0 4 Aug 4, 2021 Chief Medical Officer
ONTX Onconova Therapeutics, Inc. Jun 14, 2021 1 $0 4 Jun 17, 2021 Chief Medical Officer
ONTX Onconova Therapeutics, Inc. Jun 14, 2021 0 $0 3 Jun 17, 2021 Chief Medical Officer